Together with analyses evaluating how FOXC2 expression and subcellular localization correlate with clinicopathological features and patient outcome, these findings are likely to yield important questions related to the basic biology of FOXC2 function in melanoma that can be easily addressed in our B16-F1/B16-F1ΔFOXC2 model. Here, FOXC2 is linked to melanoma.